Tests:Cholesterol-HDL Ratio, Plasma: Difference between revisions
- Department
- Biochemistry
Tests:Cholesterol-HDL Ratio, Plasma
No edit summary |
No edit summary |
||
| Line 25: | Line 25: | ||
|- | |- | ||
|Specimen Type | |Specimen Type | ||
| | |Plasma | ||
Serum | |||
|- | |- | ||
|Preferred | |Preferred | ||
| | |6 mL <span style="background:#e30022"> Red-Top</span> | ||
|- | |- | ||
|Acceptable | |Acceptable | ||
|4 mL Li-Hep <span style="background:#3cb371"> Green-Top </span> | |||
|- | |||
|Specimen Transportation | |||
| | | | ||
|- | |- | ||
|Pediatric Requirements | |Pediatric Requirements | ||
| | |600 µL <span style="background:#99e6b3"> Li-Hep Microtainer </span> Paediatric tube | ||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
| Line 48: | Line 49: | ||
| | | | ||
|- | |- | ||
|Aliquot Transportation | | Aliquot Transportation | ||
| | | | ||
|- | |- | ||
| Line 57: | Line 58: | ||
| | | | ||
|- | |- | ||
|Test Method | |Test Method | ||
|Abbott Enzymatic reagent on the Abbott Architect ci8200 analyser | |Abbott Enzymatic reagent on the Abbott Architect ci8200 analyser | ||
|- | |- | ||
Revision as of 13:53, 31 January 2025
Overview | |
|---|---|
| Department | Biochemistry |
| Test Code | LIPS |
| Synonyms | Lipid profile |
| Turnaround Time | 2 hours |
| Stability – Add test | 24 hours |
Specimen Requirements | |
| Specimen Type | Plasma
Serum |
| Preferred | 6 mL Red-Top |
| Acceptable | 4 mL Li-Hep Green-Top |
| Specimen Transportation | |
| Pediatric Requirements | 600 µL Li-Hep Microtainer Paediatric tube |
Aliquot Requirements | |
| Sample Type | |
| Minimum Volume | |
| Aliquot Transportation | |
Clinical Information | |
| Reference Intervals | |
| Test Method | Abbott Enzymatic reagent on the Abbott Architect ci8200 analyser |
| Advanced Notice | |
| Patient Preparation | |
Comments | |
| Help for Lipid Studies Interpretation
Reported Comments: 1. All reports get this comment (see below for additional information on optimal levels): "Optimal levels are suggested by the New Zealand Guidelines Group though an individualised multi-factorial approach is preferred." 2. All reports get this comment, unless superseded by any one or more of the other comments below: "Cardiovascular risk should be addressed by lifestyle and pharmacological interventions in subjects with 5-year CV risk greater than 15%." 3. Total cholesterol >8 mmol/L or Total cholesterol/HDL ratio >8: | |